Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy
- PMID: 30579553
- DOI: 10.1016/j.jtho.2018.08.2033
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
